Background: Carpal Tunnel Syndrome (CTS) is a symptomatic compression neuropathy of the median nerve characterized by increased pressure in the carpal tunnel and decreased nerve function due to compression of the median nerve in the carpal tunnel. The purpose of the hydrodissection injection method in CTS is to separate the soft tissue adhesions that cause nerve compression and this method are known for being minimally invasive, fast healing, and easy to apply. Local injection of triamcinolone acetonide (TCA) is often used as therapy for CTS because it stabilizes the sodium channels and reduces abnormal stimulatio, thus it relieved the pain. 5% dextrose injection (D5W) is also widely used as therapy of CTS because it is harmless to nerves and may reduce neurogenic inflammation through inhibition of capsaicin-sensitive receptors. Aim: To compare the effectivity of hydrodissection injection therapy using ultrasound guidance with triamcinolone acetonide and 5% dextrose in CTS. Methods: This study recruited 30 participants who diagnosed with CTS and met the inclusion criteria. Participants were divided into two treatment groups, the first group (n=15) was given 1ml TCA injection and 1 ml lidocaine 2%, while the second group (n=15) was given 5% 5 ml Dextrose injection. The parameters measured in this study were NRS, FSS, and SSS value before injection and 4 weeks after injection of the agent. We compared these parameters at week four after injection between the TCA group and the D5W group. Results: NRS values before and 4 weeks after TCA injection (sig 0.001; p <0.05), FSS values (sig 0.020; p <0.05), and SSS values (sig 0.001; p <0.05). NRS before and 4 weeks after injection of D5W (sig 0.002; p <0.05), FSS (sig 0.001; p <0.05), and SSS (sig 0.000; p <0.05). Comparison between TCA injection and D5W injection at 4 weeks after the injection showed that the results was significantly different on NRS (sig 0.806; p> 0.05) for FSS (sig 0.512; p> 0.05) and SSS (sig 0.293; p> 0.05). Conclusion: There is a significant difference in NRS, FSS and SSS values at 4 weeks after hydrodissection injection, using either TCA or D5W. TCA hydrodissection injection compared to D5W hydrodissection injection was equally effective in improving NRS, FSS and SSS after 4 weeks of injection.
Introduction: Transverse myelitis is a rare disease that accured by incident 0,3%-1% Though it rare happened transverse myelitis deserve to diccus because the variant presentation that make clinical challenge to dianosis to pre-observation for upgrade’s prognosis. Case Report: we reported case of transverse myelitis that was neurology complication to rare herpes zoster virus. Woman 27 years old came by early complaint of tingling fever, pain, shiver continue on foot and the right hand. After got well, patient cameback to her disease bacause of the worst condition that cold not mover her left foot. Diagnosis transverse myelitis could stand through clinical sympton and magnetic resonance imaging (MRI) patient that came by her skin of hipopigment have to always considere the happening of transverse myelitis and lost control of defecate on neurologi observation being got paraplegi, monoparese extremitas superior, and hipoanesthesia dermatom C5 on low grade. We got observation of MRI to the level cervicothoracal that show long segment hipeintensity introdural intra medullary to the level craniovertebral junction so C5 and T2 so on that involved 2/3 spinal cord that strength described transverse myelitis. Discussion: Varicella zoster virus cou caused neurologis complication, the of transverse myelitis, of it is sign and sympton like pain, sencoric trouble, weakness on arm and foot, and the problem bladder and intestines. This symptom often occured unilaterally , Ipsilateral toward rash then become bilaterally. Intervention should the customize with pattient complaint: The implement combination asiklovir and high close steroid’s inject significantly relieve the pattient complaining but still occured paraplegi. Keywords: Transverse myelitis, HZV, neurological complication
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.